In this study, we want to find out what makes people decide to buy things in a convenience store.

The purpose of this study is to determine whether inactive adults are able to walk at a moderate pace (100 steps per minute) for 10 minutes when walking on a treadmill, a sidewalk, and a nature trail, and to learn about adults' feelings and mood when walking at a moderate pace. The purpose of this study is to inform future interventions focused on helping inactive adults increase their physical activity participation in fun and enjoyable ways.

The purpose of the study is to find out is AUTX-007 an investigational drug, can help treat or cure cancer.

Testing Radiation Therapy with or without Cisplatin for Head and Neck Cancer

The purpose of this study is to explore the safety and efficacy of a study drug called Telisotuzumab adizutecan (ABBV-400) in combination with existing therapies in Metastatic Colorectal Cancer (mCRC) patients.

The purpose of this study is to look at how safe and effective an investigational medication is for people who have type 1 diabetes and obesity or overweight.

Feel anxious when your body goes into "fight or flight?" You may be eligible to participate in a research study to learn how difficult emotions, such as anxiety and fear, relate to feelings in the body. Compensation provided.

Ever wonder how the way you walk may affect your knees? Have you ever had an ACL reconstruction? You may be able to take part in a study to learn more about how different types of force applied to your legs can affect your knee while walking on a treadmill.

Has your partner ever used a gun to hurt or scare you? Have you ever filed for a protective order in North Carolina? If so, we'd like to talk to you about your experiences. Click the link to find out if you qualify for a research study about domestic violence protective orders and guns. Participation includes a phone interview and compensation is provided.

The purpose of this research is to test the safety of NXC-201 (a CAR-T cell targeting the BCMA protein) at different doses in participants with relapsed/refractory AL amyloidosis, and to confirm the best dose for further testing. In addition, the study will evaluate the effectiveness of NXC-201 in treating relapsed/refractory AL amyloidosis